Chapter 1.  Proton Therapy for Central Nervous System (CNS) Cancer Market – Scope & Methodology
1.1    Market Segmentation
1.2    Scope, Assumptions & Limitations
1.3    Research Methodology
1.4    Primary Sources
1.5    Secondary Sources
 
Chapter 2.  Proton Therapy for Central Nervous System (CNS) Cancer Market – Executive Summary
2.1    Market Size & Forecast – (2022 – 2030) ($M/$Bn)
2.2    Key Trends & Insights
           2.2.1    Demand Side
          2.2.2    Supply Side
2.3    Attractive Investment Propositions
2.4    COVID-19 Impact Analysis
 
Chapter 3.  Proton Therapy for Central Nervous System (CNS) Cancer Market – Competition Scenario
3.1    Market Share Analysis & Company Benchmarking
3.2    Competitive Strategy & Development Scenario
3.3    Competitive Pricing Analysis
3.4    Supplier-Distributor Analysis
  
Chapter 4.  Proton Therapy for Central Nervous System (CNS) Cancer Market Entry Scenario
4.1    Regulatory Scenario
4.2    Case Studies – Key Start-ups
4.3    Customer Analysis
4.4    PESTLE Analysis
4.5    Porters Five Force Model
          4.5.1    Bargaining Power of Suppliers
          4.5.2    Bargaining Powers of Customers
          4.5.3    Threat of New Entrants
          4.5.4    Rivalry among Existing Players
          4.5.5    Threat of Substitutes
 
Chapter 5.  Proton Therapy for Central Nervous System (CNS) Cancer Market – Landscape
5.1    Value Chain Analysis – Key Stakeholders Impact Analysis
5.2    Market Drivers
5.3    Market Restraints/Challenges
5.4    Market Opportunities
 
Chapter 6.  Proton Therapy for Central Nervous System (CNS) Cancer Market – End-User
6.1    Introduction/Key Findings   
6.2    Private hospitals 
6.3    Specialized cancer treatment centers
6.4    Y-O-Y Growth trend Analysis End-User
6.5    Absolute $ Opportunity Analysis End-User, 2023-2030
   
Chapter 7.  Proton Therapy for Central Nervous System (CNS) Cancer Market , By Geography – Market Size, Forecast, Trends & Insights
7.1    North America
          7.1.1    By Country
                    7.1.1.1    U.S.A.
                    7.1.1.2    Canada
          7.1.1.3    Mexico
          7.1.2    End-User
          7.1.3    Countries & Segments - Market Attractiveness Analysis
7.2    Europe
          7.2.1    By Country
          7.2.1.1    U.K
          7.2.1.2    Germany
          7.2.1.3    France
          7.2.1.4    Italy
          7.2.1.5    Spain
          7.2.1.6    Rest of Europe
          7.2.2    End-User
          7.2.3    Countries & Segments - Market Attractiveness Analysis
7.3    Asia Pacific
          7.3.1    By Country
                    7.3.1.1    China
                    7.3.1.2    Japan         
                    7.3.1.3    South Korea
                    7.3.1.4    India      
                    7.3.1.5    Australia & New Zealand
                    7.3.1.6    Rest of Asia-Pacific
          7.3.2    End-User
          7.3.3    Countries & Segments - Market Attractiveness Analysis
7.4    South America
          7.4.1    By Country
                    7.4.1.1    Brazil
                    7.4.1.2    Argentina
                    7.4.1.3    Colombia
                    7.4.1.4    Chile
                    7.4.1.5    Rest of South America
          7.4.2    End-User
          7.4.3    Countries & Segments - Market Attractiveness Analysis
7.5    Middle East & Africa
          7.5.1    By Country
                    7.5.1.1    United Arab Emirates (UAE)         
                    7.5.1.2    Saudi Arabia
                    7.5.1.3    Qatar
                    7.5.1.4    Israel
                    7.5.1.5    South Africa
                    7.5.1.6    Nigeria
                    7.5.1.7    Kenya
                    7.5.1.8    Egypt
                    7.5.1.9    Rest of MEA
          7.5.2    End-User
          7.5.3    Countries & Segments - Market Attractiveness Analysis         
 
Chapter 8.  Proton Therapy for Central Nervous System (CNS) Cancer Market – Company Profiles – (Overview, Product Portfolio, Financials, Strategies & Developments)
8.1    Varian Medical Systems
8.2    IBA Proton Therapy
8.3    Mevion Medical Systems
8.4    ProTom International
8.5    ProNova Solutions
8.6    Sumitomo Heavy Industries, Ltd.
8.7    National Cancer Center Hospital
8.8    Anderson Proton Therapy Center